Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Parallel track

Executive Summary

To be reviewed at National Institutes of Health meeting on Dec. 3. The clinical research subcommittee of the National Institute of Allergy and Infectious Diseases' AIDS Research Advisory Committee (ARAC) will hear presentations on the progress of the parallel track program by FDA, PMA, Bristol-Myers Squibb (which is testing ddl), and AIDS activist group ACT UP. Hoffman-La Roche will also discuss its experience with expanded access for ddC.
UsernamePublicRestriction

Register

PS018422

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel